Navigation Links
Smoking, high blood pressure and cholesterol can be fatal for hemorrhage survivors
Date:1/14/2013

"It is particularly important for subarachnoid haemorrhage survivors to refrain from smoking and to take care of their blood pressure and cholesterol levels; apart from age, these are the primary factors behind the increased risk of mortality," explains neurosurgeon Miikka Korja from the HUCH's Neurosurgery Department together with professor Jaakko Kaprio from the University of Helsinki's Hjelt Institute.

The most extensive population-based follow-up study ever carried out on the subject, jointly conducted by HUCH, the University of Helsinki, and the Finnish National Institute for Health and Welfare, examined the mortality rate of patients who had experienced SAH, as well as the reasons behind the mortality rate. The study has been published in the leading neurological publication, Neurology (2013 Jan 9 Epub ahead of print).

The research subjects were Finns between the ages of 25 and 74, who had participated in the national FINRISK study between 1972 and 2007. Out of the total of 64,000 Finns, 437 suffered a subarachnoid haemorrhage during the research period, and 233 of them were alive when one year had passed of the episode. Follow-up continued till the end of 2009, with the median of the follow-up period being 8.6 years.

Of the 233 patients still alive after one year had passed since the subarachnoid haemorrhage, 88 (37.8%) died within the follow-up period. Mortality in this group was approximately double when compared to that of the general population, with the age and gender distribution taken into account. Examination of the causes of death revealed that the increased mortality was solely due to lethal occurrences in the blood circulation of the brain, such as strokes or internal bleeding.

The risk of mortality was particularly increased by smoking and a high cholesterol level and high systolic blood pressure already found before the subarachnoid haemorrhage.

"When comparing the continued mortality of SAH survivors to the general population that did not smoke and had low blood pressure and low cholesterol levels, the risk of mortality showed an increase of 31 persons per thousand person-years", Korja says.

"In other words, if 20 out of 100 non-smokers with low blood pressure and cholesterol would die within the next 10 years, the figure for SAH survivors would be 51."

By intervening on risk factors, secondary prevention of cerebrovascular events may prevent early deaths of SAH survivors

The researchers state that considerably more attention should be paid to risk factors in the life of SAH survivors.

"Lifestyle and risk factors should be discussed with the patient, as they are nearly as important as the treatment of the acute phase of the illness," Korja points out.

Finnish researchers already showed in a previous study, based on the most extensive twin data in the world, that the primary reasons behind SAH are related to the patient's way of life, not individual genes that may predispose people to the illness.

"Changes in the way of life may reduce both the occurrence of SAH as well as the mortality of patients who have recovered from it," Kaprio says emphatically.


'/>"/>
Contact: Dr. Miikka Korja
mkorja@mqneurosurgery.com
61-298-123-898
University of Helsinki
Source:Eurekalert

Related medicine news :

1. AddictionFreeCanada.com, At a Recent Press Briefing, Offered Solutions to Dangers Caused by Smoking, Drinking and Gambling.
2. Seniors with serious illness find smoking, drinking tough habits to break
3. Smoking, Pesticides Might Spur Rare Sleep-Kicking Disorder
4. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds
5. Fewer Young Americans Smoking, Survey Finds
6. Exercise helps smokers to quit smoking, to remain smoke-free and to reduce the risk of death
7. Anti-tobacco TV ads help adults stop smoking, study finds
8. US Drug Watchdog Now Puts a New Emphasis on DePuy Pinnacle Hip Implant Recipients and They Urge Them to Get a Blood Test for Elevated Metals Levels
9. Blood Pressure Monitoring and Measurement Instruments Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
10. Blood Disorder Cases Tied to Prescription Painkiller Abuse
11. This week in Blood: Jan. 10, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... ... 2017 , ... “Reflections of God’s Work”: an enlightening collection of life lessons ... creation of published author, Jerri Broglin, a survivor of great loss who gained insight ... great eye-opener for those searching for answers, as we are finding the answers that ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist ... 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held ... its annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a ... systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has ... the product advances towards regulatory and clinical phases. , "This is another important ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: